Results 61 to 70 of about 2,381,877 (194)

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)

International Journal of Gynecological Pathology, 2018
Although endometrial carcinoma (EC) is generally considered to have a good prognosis, over 20% of women with EC die of their disease, with a projected increase in both incidence and mortality over the next few decades. The aim of accurate prognostication
Naveena Singh, L. Hirschowitz, R. Zaino, I. Alvarado-Cabrero, M. Duggan, R. Ali-Fehmi, E. Euscher, J. Hecht, L. Horn, O. Ioffe, X. Matías-Guiu, W. McCluggage, Y. Mikami, J. Ordi, V. Parkash, M. Quddus, C. Quick, A. Staebler, C. Zaloudek, M. Nucci, A. Malpica, E. Oliva   +21 more
semanticscholar   +1 more source

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

British Journal of Cancer, 2018
PORTEC-2 was a randomised trial for women with high-intermediate risk (HIR) endometrial cancer, comparing pelvic external beam radiotherapy (EBRT) with vaginal brachytherapy (VBT).
B. Wortman, C. Creutzberg, H. Putter, I. Jürgenliemk-Schulz, J. Jobsen, L. Lutgens, E. M. van der Steen-Banasik, J. Mens, A. Slot, M. C. Stenfert Kroese, B. van Triest, H. Nijman, E. Stelloo, T. Bosse, S. D. de Boer, W. V. van Putten, V. Smit, Remi A. Nout   +17 more
semanticscholar   +1 more source

Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods

Pathology and Oncology Research, 2022
Purpose: Our purpose was to systematically appraise the clinicopathological significance and explore the molecular bases of CKS2 in endometrial carcinoma.Patients and Methods: We measured the clinicopathological significance of CKS2 using diverse methods
Li Gao, Gang Chen, Zi-Qian Liang, Jian-Di Li, Dong-Ming Li, Yu-Lu Tang, Deng Tang, Zhi-Guang Huang, Jun-Hong Chen, Jia-Yuan Luo, Jiang-Hui Zeng, Yi-Wu Dang, Zhen-Bo Feng   +12 more
doaj   +1 more source

Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma

Clinical Cancer Research, 2018
Purpose: Tumors with high mutation load are thought to engender stronger immune responses, which in turn promote prolonged patient survival. To investigate this, we assessed tumor-infiltrating lymphocytes (TILs) and immunosuppressive factors across the 4
A. Talhouk, H. Derocher, Pascal Schmidt, S. Leung, K. Milne, C. Gilks, M. Anglesio, B. Nelson, J. McAlpine   +8 more
semanticscholar   +1 more source

Bmi-1 Immunohistochemical Expression in Endometrial Carcinoma is Correlated with Prognostic Activity

Medicina, 2020
Background and objectives: B-lymphoma Mo-MLV insertion region 1 (Bmi-1) is a stem cell factor that is overexpressed in various human cancer tissues.
Kayo Horie, Chihiro Iseki, Moe Kikuchi, Keita Miyakawa, Mao Yoshizaki, Haruhiko Yoshioka, Jun Watanabe   +6 more
doaj   +1 more source

Diagnostic accuracy of different endometrial sampling tests for detecting endometrial carcinoma and its precursors

, 2023
A Systematic review and metanalysis of the diagnostic accuracy of different endometrial sampling tests for detecting endometrial carcinoma and its ...
Ashraf Nabhan
core   +1 more source

Results of Postoperative Treatments in View of the Surgical Stage of Uterine Endometrial Carcinoma [PDF]

, 1997
Background : The indications for and the optimal mode of adjuvant therapy in surgically operated endometrial cancer patients have not yet been established. We studied the indications for the postoperative treatment of endometrial carcinoma patients based
Moriyama, Shingo, Ishimaru, Tadayuki, Nakajima, Hisayoshi, Sakai, Hidetaka, Yamabe, Tooru   +4 more
core  

Role of Ki 67 in Normal Endometrium, Endometrial Hyperplasia and Endometrial Carcinoma: A Comparative Study [PDF]

, 2023
Introduction: Endometrial carcinoma is the 4th most common malignancy inwomen and its incidence is increasing both in developed and developing countries.
K.T Athulya Krishna Kumar, Krishnaraj Upadhyaya, Ravi Teja Cn
core   +1 more source

Undifferentiated endometrial carcinoma diagnosed during perimenopausal hormone therapy: a case report and literature review

Frontiers in Oncology
Uterine corpus endometrial carcinoma, one of the three most frequent cancers of the female reproductive system, primarily affects women who are perimenopausal or postmenopausal. Moreover, it is an epithelial cancer that develops in the endometrium, which
Ying Wang, Yu-Tong Zheng, Ling Zhang, Xue-Quan Cao, Zhu Lin, Hong-Yu Liu, Qiong-Ying Hu   +6 more
doaj   +1 more source

Recurrence-related Factors of 46 Stage Ⅰ-Ⅱ Endometrial Carcinoma Patients

Zhongliu Fangzhi Yanjiu, 2019
Objective To investigate the risk factors of the recurrence of stage Ⅰ-Ⅱ endometrial carcinoma. Methods We retrospectively analyzed the data of 516 patients with stage Ⅰ-Ⅱ endometrial carcinoma treated in Nanjing Drum Tower Hospital from January 2010 to ...
ZHANG Zhengyu, LING Jingxian, LI Rong, HAN Ke, ZHU Xianghong, TANG Xiaoqiu, ZHOU Huaijun   +6 more
doaj   +1 more source